Kroger is well-positioned amid tightening consumer spending, with private labels offering value and supporting steady performance in an uncertain market environment. Private labels drive higher margins and customer loyalty, making Kroger resilient during economic slowdowns and potentially building a durable customer base. Kroger's valuation remains reasonable compared to peers, and its historical performance during recessions suggests stability and potential for long-term gains.

image for news Kroger's Earnings And Why Private Labels Are Especially Appetizing Right Now

Plug Power's Electrolyzer Sales Jump in Q1: Can the Momentum Sustain? — Positive

PLUG   Zacks Investment Research — June 20, 2025

PLUG's electrolyzer revenues soar in Q1 2025, fueled by rising global demand for green hydrogen solutions.

image for news Plug Power's Electrolyzer Sales Jump in Q1: Can the Momentum Sustain?

Can Vistra Benefit From the Clean Energy Transition & Net-Zero Goal? — Positive

VST   Zacks Investment Research — June 20, 2025

VST targets net-zero emissions by 2050, retiring fossil assets and ramping up renewables to boost earnings.

image for news Can Vistra Benefit From the Clean Energy Transition & Net-Zero Goal?

Qualcomm vs. AMD: Which Chipmaker Offers Stronger Growth in 2025? — Positive

AMD  QCOM   Zacks Investment Research — June 20, 2025

AMD's strong AI momentum and faster sales growth for 2025 may give it the edge over QCOM, despite higher valuation.

image for news Qualcomm vs. AMD: Which Chipmaker Offers Stronger Growth in 2025?

The average of price targets set by Wall Street analysts indicates a potential upside of 93.7% in Knot Offshore (KNOP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

image for news Wall Street Analysts Predict a 93.68% Upside in Knot Offshore (KNOP): Here's What You Should Know

KB Home KBH will release earnings results for the second quarter, after the closing bell on Monday, June 23.

image for news KB Home Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Dividends Under $30: Don't Miss This 7.3% High-Yield Stock — Positive

ET   24/7 Wall Street — June 20, 2025

Some dividend stocks are much safer than others, and ET is one of them. The underlying business is recession-resistant and tariff-resistant.

image for news Dividends Under $30: Don't Miss This 7.3% High-Yield Stock

FedEx is down 20% YTD in '25 and down -7.77% in the last twelve months after guiding lower for fiscal Q4 '25 in March '25, and has now guided the last 3 quarters lower, despite the focus on reducing FedEx's cost structure by $2 billion. FedEx stock is about 10% -15% cheap to perceived intrinsic value. The negative EPS and revenue revisions are the biggest issue around FedEx right now.

image for news FedEx Earnings Preview: Valuation Getting Compelling, But Negative Revisions Continue

Spectrum Brands Holdings: Pain Should Be Short-Term — Negative

SPB   Seeking Alpha — June 20, 2025

Despite recent underperformance and weak top/bottom line results, Spectrum Brands shares remain attractively valued, especially for long-term investors willing to accept risk. The company's Home & Garden segment shows resilience, but other segments face volume and pricing pressures, particularly due to economic headwinds and tariffs. Management's ongoing efforts to reduce debt, cut costs, and potentially spin off the HPC segment could unlock shareholder value, though timing remains uncertain.

image for news Spectrum Brands Holdings: Pain Should Be Short-Term

Why Charter Communications (CHTR) is a Top Growth Stock for the Long-Term — Positive

CHTR   Zacks Investment Research — June 20, 2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Why Charter Communications (CHTR) is a Top Growth Stock for the Long-Term

Here's Why Celestica (CLS) is a Strong Growth Stock — Positive

CLS   Zacks Investment Research — June 20, 2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Here's Why Celestica (CLS) is a Strong Growth Stock

Why CACI International (CACI) is a Top Growth Stock for the Long-Term — Positive

CACI   Zacks Investment Research — June 20, 2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Why CACI International (CACI) is a Top Growth Stock for the Long-Term

Why Ensign Group (ENSG) is a Top Growth Stock for the Long-Term — Positive

ENSG   Zacks Investment Research — June 20, 2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Why Ensign Group (ENSG) is a Top Growth Stock for the Long-Term

Here's Why Qiagen (QGEN) is a Strong Growth Stock — Positive

QGEN   Zacks Investment Research — June 20, 2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

image for news Here's Why Qiagen (QGEN) is a Strong Growth Stock

Why Danaher (DHR) is a Top Growth Stock for the Long-Term — Positive

DHR   Zacks Investment Research — June 20, 2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Why Danaher (DHR) is a Top Growth Stock for the Long-Term

Disney Focuses on Expanding Theme Park Business: Can the Plan Deliver? — Positive

DIS   Zacks Investment Research — June 20, 2025

DIS commits $60 billion to expand parks and cruises, betting on global growth as strong bookings boost 2025 outlook.

image for news Disney Focuses on Expanding Theme Park Business: Can the Plan Deliver?

Sanofi & Regeneron's Dupixent Gets FDA Nod for Bullous Pemphigoid — Positive

REGN  SNY   Zacks Investment Research — June 20, 2025

SNY and REGN's Dupixent gets FDA approval for a rare and chronic skin disease, marking its eighth approved indication for the drug.

image for news Sanofi & Regeneron's Dupixent Gets FDA Nod for Bullous Pemphigoid

Will Carvana Extend Its Streak of Record Retail Sales in Q2? — Positive

CVNA   Zacks Investment Research — June 20, 2025

CVNA's record Q1 sales and rising momentum set the stage for a possible fifth straight quarter of growth.

image for news Will Carvana Extend Its Streak of Record Retail Sales in Q2?

Equinor Secures UK Floating Wind Leases in Celtic Sea Push — Neutral

EQNR   Zacks Investment Research — June 20, 2025

EQNR secures a 1.5 GW floating wind lease in the Celtic Sea, advancing UK net-zero goals and offshore wind growth.

image for news Equinor Secures UK Floating Wind Leases in Celtic Sea Push

Restaurant Stocks Struggle: 3 Companies are Defying the Odds — Neutral

CBRL  SHAK  WING   Zacks Investment Research — June 20, 2025

CBRL, SHAK and WING are sizzling as the restaurant sector cools, with each posting double-digit gains and raising earnings estimates.

image for news Restaurant Stocks Struggle: 3 Companies are Defying the Odds